Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin Lymphoma.
Mei M, Tsai NC, Palmer J, Armenian S, Chen R, Rosen S, Forman S, Popplewell L, Kwak L, Martin P, Maddocks K, Bond D, Herrera AF.
Mei M, et al. Among authors: herrera af.
Clin Lymphoma Myeloma Leuk. 2024 Apr 10:S2152-2650(24)00148-4. doi: 10.1016/j.clml.2024.03.013. Online ahead of print.
Clin Lymphoma Myeloma Leuk. 2024.
PMID: 38693037